Epidemiological characterization of the intermittent and persistent types of allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 3, 2005, Pages 350-353

  Bauchau, V ^a   Durham, S R ^b  

^a UCB PHARMA   (Belgium)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergic rhinitis and its impact on asthma; Epidemiology; Intermittent allergic rhinitis; Persistent allergic rhinitis

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; HAY FEVER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PERENNIAL RHINITIS; POPULATION RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIZATION; SYMPTOM; VALIDATION PROCESS; WESTERN EUROPE;

ADULT; AWARENESS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INCIDENCE; INTERVIEWS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 14344252103     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00751.x     Document Type: Article

References (10)

1. Bousquet J, van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl. 5):S147-S334.
2. Ciprandi G, Vizzaccaro A, Cirillo I, Crimi P, Canonica GW. Increase of asthma and allergic rhinitis prevalence in young Italian men. Int Arch Allergy Immunol 1996;111:278-283.
3. Jones NS, Smith PA, Carney AS, Davis A. The prevalence of allergic rhinitis and nasal symptoms in Nottingham. Clin Otolaryngol 1998;23:547-554.
4. Didier A, Chanal I, Klossek JM, Mathieu J. La rhinite allergique: le point de vue du patient. Revue Française Allergologie 1999;39:171-185.
5. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manage Care 2000;6:373-378.
6. Demoly P, Allaert FA, Lecasble M, Bousquet J, PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003;58:672-675.
7. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-764.
8. Bousquet J, van Cauwenberge P, Khalataev N and the ARIA Workshop. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergy 2004;59:373-387.
9. Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A et al. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects. Allergy 2004;59:406-414.
10. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J et al. Levocetirizine improves quality-of-life and reduces costs in long term treatment of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114: 838-844.